ANDA Sponsors Urged To Ask DMF Holders About 'Hidden Facilities'
Executive Summary
FDA says 16% of ANDAs have an issue with "hidden facilities" that are listed in drug master files but not the ANDAs they are linked with; industry official offers some tips to bridge this communications gap with DMF holders.